Paper2355431
Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy.
Pierce LR and 2 others. JAMA, 1990. Cited by 386 papers, by iCite.
Cite this record
ConductScience Library. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. Papers, record 2355431. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2355431
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gemfibrozil | Major topic |
| Lovastatin | Major topic |
| Muscular Diseases | Major topic |
| Rhabdomyolysis | Major topic |
| Acute Kidney Injury | |
| Adult | |
| Aged | |
| Creatine Kinase | |
| Drug Interactions | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Hypercholesterolemia | |
| Male | |
| Middle Aged |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 2243420 | Myopathy and rhabdomyolysis with lovastatin taken with gemfibrozil. | https://conductscience.org/library/papers/2243420 |
Source PubMed
Cited by72
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 386 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39275243 | Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review. | Nutrients | 2024 | https://conductscience.org/library/papers/39275243 | PubMed |
| 38925925 | Once-daily Extended-Release Pemafibrate Enhances Adherence and Triglyceride Control Over Twice-Daily Dosing. | J Atheroscler Thromb | 2024 | https://conductscience.org/library/papers/38925925 | PubMed |
| 38907023 | Clinical and pathological aspects of toxic myopathies. | J Neurol | 2024 | https://conductscience.org/library/papers/38907023 | PubMed |
| 38776276 | Outlier analysis for accelerating clinical discovery: An augmented intelligence framework and a systematic review. | PLOS Digit Health | 2024 | https://conductscience.org/library/papers/38776276 | PubMed |
| 34219515 | Statin-Induced Autoimmune Necrotizing Myopathy. | J Prim Care Community Health | 2021 | https://conductscience.org/library/papers/34219515 | PubMed |
| 33045618 | Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK. | Atherosclerosis | 2020 | https://conductscience.org/library/papers/33045618 | PubMed |
| 31819247 | Primary biliary cholangitis: pathogenesis and therapeutic opportunities. | Nat Rev Gastroenterol Hepatol | 2020 | https://conductscience.org/library/papers/31819247 | PubMed |
| 31624609 | Tendon rupture associated with concomitant simvastatin and gemfibrozil use: Biological and pharmacokinetic implications. | Clin Case Rep | 2019 | https://conductscience.org/library/papers/31624609 | PubMed |
| 29784023 | Delayed presentation of severe rhabdomyolysis leading to acute kidney injury following atorvastatin-gemfibrozil combination therapy: a case report. | J Med Case Rep | 2018 | https://conductscience.org/library/papers/29784023 | PubMed |
| 28793934 | Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism. | Microbiome | 2017 | https://conductscience.org/library/papers/28793934 | PubMed |
| 26085109 | Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis. | Adv Healthc Mater | 2015 | https://conductscience.org/library/papers/26085109 | PubMed |
| 25696757 | Safety of statins in the new millennium. | Neth Heart J | 2001 | https://conductscience.org/library/papers/25696757 | PubMed |
| 25678132 | Fibrates and cholestasis. | Hepatology | 2015 | https://conductscience.org/library/papers/25678132 | PubMed |
| 25131449 | HDL and cognition in neurodegenerative disorders. | Neurobiol Dis | 2014 | https://conductscience.org/library/papers/25131449 | PubMed |
| 24971331 | Antiartherosclerotic effects of plant flavonoids. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/24971331 | PubMed |
| 24897241 | Phenotype standardization for statin-induced myotoxicity. | Clin Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24897241 | PubMed |
| 24668570 | No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population. | Mol Biol Rep | 2014 | https://conductscience.org/library/papers/24668570 | PubMed |
| 24454313 | Dyslipidemia in patients with chronic and end-stage kidney disease. | Cardiorenal Med | 2013 | https://conductscience.org/library/papers/24454313 | PubMed |
| 24083205 | A comparative study of efficacy of atorvastatin alone and its combination with fenofibrate on lipid profile in type 2 diabetes mellitus patients with hyperlipidemia. | J Adv Pharm Technol Res | 2013 | https://conductscience.org/library/papers/24083205 | PubMed |
| 23962548 | Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. | Clin Gastroenterol Hepatol | 2014 | https://conductscience.org/library/papers/23962548 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2355431
GET https://conductscience.org/api/papers/v1/2355431/cited_by?page=2